申请人:Korea Research Institute of Bioscience and Biotechnology
公开号:US07723376B2
公开(公告)日:2010-05-25
The present invention is related to novel use of 2-oxo-heterocyclic compounds having anticancer activity and the process for preparing them and a pharmaceutical composition comprising the same. The present invention provides a pharmaceutical composition for preventing and treating the cancer disease comprising lung cancer, bone cancer, pancreatic cancer, skin cancer, cancer of the head and neck, cutaneous or intraocular melanoma, uterine cancer, ovarian cancer, rectal cancer or cancer of the anal region, stomach cancer, colon cancer, breast cancer, gynecologic tumors, Hodgkin's disease, cancer of the esophagus, cancer of the small intestine, cancer of the endocrine system, sarcomas of soft tissues, cancer of the urethra, cancer of the penis, prostate cancer, chronic or acute leukemia, solid tumors of childhood, lymphocytic lymphonas, cancer of the bladder, cancer of the kidney or ureter, or neoplasms of the central nervous system, therefore, it can be used as the therapeutics for treating and preventing cancer diseases.
本发明涉及具有抗癌活性的2-氧代杂环化合物的新用途及其制备过程,以及包含它们的药物组合物。本发明提供了一种用于预防和治疗肺癌、骨癌、胰腺癌、皮肤癌、头颈部癌症、皮肤或眼内黑色素瘤、子宫癌、卵巢癌、直肠癌或肛门癌、胃癌、结肠癌、乳腺癌、妇科肿瘤、霍奇金病、食管癌、小肠癌、内分泌系统癌症、软组织肉瘤、尿道癌、阴茎癌、前列腺癌、慢性或急性白血病、儿童实体瘤、淋巴细胞淋巴瘤、膀胱癌、肾或输尿管癌或中枢神经系统肿瘤的肿瘤疾病的药物组合物,因此,它可以作为治疗和预防癌症疾病的治疗剂。